David M. Naseman is senior counsel and a member of the Corporate Group at Crowell & Moring's Washington office, and specializes in analyzing complex business proposals and legal relationships, developing effective and innovative solutions, and crafting agreements to address clients'; long-term objectives and risk management criteria. David has practiced in New York City, Washington, DC and London representing public and private companies in a wide range of corporate, securities, financing, governance and transactional matters throughout the United States and internationally. David's extensive corporate experience includes negotiated and contested takeovers, proxy contests, leveraged buyouts, IPO and private financing transactions and customary M&A deals, and serving as counselor to boards of directors and special committees dealing with interested transactions, investigations and other sensitive matters.
Throughout his career, David has served as a consummate advisor to start-up entrepreneurs as well as established companies in developing businesses and products involving new and emerging technologies as well as innovations in traditional industries. David is not only expert at negotiating joint ventures, alliances and partnering relationships and structuring and implementing management and financial arrangements tailored to the particular needs and objectives of his clients, but also has in-depth experience in working closely with CEOs, CFOs and executives and managers at all levels in constructing the requisite suite of vendor, outsourcing and other operational agreements as well as internal plans, policies and procedures necessary for a business to thrive at any stage of its development.
During his tenure as an executive and the Chief Legal Officer of LIN Broadcasting Corporation, David was instrumental in fashioning and executing LIN's business and legal strategies as a pioneer of mobile communications in five of the nation's ten largest markets, resulting in a $6.5 billion increase in LIN's market value during the 1980s and early 1990s. He returned to private practice as an equity partner of Blumenfeld & Cohen and Gray Cary Ware & Freidenrich LLP before joining Crowell & Moring in 2004.
David has advised clients on matters before federal and state commissions and agencies (including the Department of Justice, the Federal Communications Commission and the Securities and Exchange Commission), and in various state and federal courts (including the Delaware Chancery Court). David has also served as a member of, or counsel to, boards and committees of nonprofit and trade associations (including those engaged in electronic information management and medical services), and over the years has advised clients involved in industries such as natural resources, specialty chemicals, broadcasting and cable, financial services, web hosting, telecommunications, publishing, banking, transportation, e-commerce, network architecture and programming, and database services and the acquisition and leasing of MMDS and ITFS spectrum.
A graduate of Boston University majoring in economics and political science, David received his J.D. (with highest honors) from Tulane University School of Law in 1975, where he served as Managing Editor of the Law Review. He is admitted to practice in the State of New York and the District of Columbia.
In 2012, David was honored by AHLA Connections, the monthly magazine of the American Health Lawyers Association, by being named to the publication's first annual class of AHLA "Pro Bono Champions." The recognition came for his legal assistance to the District of Columbia Primary Care Association in implementing its Medical Homes project to improve health care access for the poor, uninsured and underinsured residents of Washington, D.C.
Speaking Engagements
· "Legal Considerations in Structuring Collaborative Arrangements," NANOTECHNOLOGY 2006, Rensselaer Polytechnic Institute Conference Center in Troy, New York (September 26, 2006). Speaker: David M. Naseman.
· "Threshold Legal Considerations for Organizing, Financing and Operating Early-Stage Ventures," Strategic Research Institute's Conference on NANOMEDICINE: Commercializing Drug Discovery, Delivery & Diagnostics, Cambridge, Massachusetts (October 4, 2005). Speaker: David M. Naseman.